Everspin Press Releases
View printer-friendly version << Back
Everspin Reports Second Quarter 2020 Financial Results
Second Quarter and Recent Highlights
-
Total revenue increased 37% year-over-year and 17% sequentially to
$11.8 million - Operating expenses declined 18% over the prior year period
-
GAAP loss improved to
$1.3 million , or ($0.07 ) per share, and non-GAAP loss to$0.4 million , or ($0.02 ), compared to$3.7 million , or ($0.21 ) per share, and$2.9 million , or ($0.17 ) per share, respectively, in the second quarter of 2019 -
Achieved positive adjusted EBITDA of
$0.2 million , compared to a negative($2.2) million in the year-ago quarter -
Appointed Daniel Berenbaum CFO bringing strong semiconductor finance and
Wall Street experience to the executive team -
Ended quarter with cash and equivalents of
$12.9 million
“We extended our momentum into the second quarter, achieving the fourth consecutive quarter of growth including record revenue from the ramp of our 1Gb STT-MRAM product,” stated
“Entering the third quarter, we are seeing a delay of customers’ new product introduction plans, resulting in reduced visibility and expectations for the quarter. Despite these current market challenges, we remain encouraged about our future growth opportunities, growing pipeline of business and improved financial positioning.”
Second Quarter 2020 Results
Total revenue for the second quarter of 2020 was
Gross margin for the second quarter of 2020 was 43.9%, compared to 52.9% in the prior quarter and 46.5% in the second quarter of 2019.
GAAP operating expenses for the second quarter of 2020 decreased to
GAAP net loss for the second quarter of 2020 was
On a non-GAAP basis, net loss for the second quarter of 2020 was
Adjusted EBITDA for the second quarter of 2020 improved to a positive
Cash and cash equivalents as of
Business Outlook
For the third quarter of 2020,
Conference Call
A telephone replay of the conference call will be available approximately two hours after the call through
About
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding future results that involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements, including, but not limited to the statements made under the caption “Business Outlook.” Actual results could differ materially from these forward-looking statements as a result of certain factors, including, without limitation, the risks set forth in Everspin’s Form 10-Qs filed with the
Condensed Balance Sheets (In thousands, except share and per share amounts) (Unaudited) |
||||||||
|
||||||||
|
|
|
|
|
||||
|
|
2020 |
|
2019 |
||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
12,916 |
|
|
$ |
14,487 |
|
Accounts receivable, net |
|
|
7,339 |
|
|
|
5,799 |
|
Inventory |
|
|
8,368 |
|
|
|
7,863 |
|
Prepaid expenses and other current assets |
|
|
501 |
|
|
|
539 |
|
Total current assets |
|
|
29,124 |
|
|
|
28,688 |
|
Property and equipment, net |
|
|
2,908 |
|
|
|
3,479 |
|
Right-of-use assets |
|
|
2,985 |
|
|
|
3,132 |
|
Other assets |
|
|
73 |
|
|
|
73 |
|
Total assets |
|
$ |
35,090 |
|
|
$ |
35,372 |
|
|
|
|
|
|
|
|
||
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
2,074 |
|
|
$ |
2,873 |
|
Accrued liabilities |
|
|
1,392 |
|
|
|
2,727 |
|
Current portion of long-term debt |
|
|
1,073 |
|
|
|
670 |
|
Operating lease liabilities |
|
|
1,546 |
|
|
|
1,582 |
|
Other liabilities |
|
|
44 |
|
|
|
42 |
|
Total current liabilities |
|
|
6,129 |
|
|
|
7,894 |
|
Long-term debt, net of current portion |
|
|
6,893 |
|
|
|
7,149 |
|
Operating lease liabilities, net of current portion |
|
|
1,656 |
|
|
|
1,840 |
|
Total liabilities |
|
|
14,678 |
|
|
|
16,883 |
|
Commitments and contingencies |
|
|
|
|
|
|
||
Stockholders’ equity: |
|
|
|
|
|
|
||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
172,098 |
|
|
|
167,149 |
|
Accumulated deficit |
|
|
(151,688 |
) |
|
|
(148,662 |
) |
Total stockholders’ equity |
|
|
20,412 |
|
|
|
18,489 |
|
Total liabilities and stockholders’ equity |
|
$ |
35,090 |
|
|
$ |
35,372 |
|
Condensed Statements of Operations and Comprehensive Loss (In thousands, except share and per share amounts) (Unaudited) |
|||||||||||||||||
|
|||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
||||||||
Product sales |
|
$ |
10,927 |
|
|
$ |
8,003 |
|
|
$ |
20,562 |
|
|
$ |
17,026 |
|
|
Licensing, royalty, and other revenue |
|
|
899 |
|
|
|
643 |
|
|
|
1,372 |
|
|
|
1,646 |
|
|
Total revenue |
|
|
11,826 |
|
|
|
8,646 |
|
|
|
21,934 |
|
|
|
18,672 |
|
|
Cost of sales |
|
|
6,635 |
|
|
|
4,627 |
|
|
|
11,392 |
|
|
|
9,868 |
|
|
Gross profit |
|
|
5,191 |
|
|
|
4,019 |
|
|
|
10,542 |
|
|
|
8,804 |
|
|
Operating expenses:1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
|
2,774 |
|
|
|
3,519 |
|
|
|
5,804 |
|
|
|
7,517 |
|
|
General and administrative |
|
|
2,448 |
|
|
|
2,856 |
|
|
|
5,248 |
|
|
|
6,451 |
|
|
Sales and marketing |
|
|
1,056 |
|
|
|
1,239 |
|
|
|
2,159 |
|
|
|
2,603 |
|
|
Total operating expenses |
|
|
6,278 |
|
|
|
7,614 |
|
|
|
13,211 |
|
|
|
16,571 |
|
|
Loss from operations |
|
|
(1,087 |
) |
|
|
(3,595 |
) |
|
|
(2,669 |
) |
|
|
(7,767 |
) |
|
Interest expense |
|
|
(172 |
) |
|
|
(186 |
) |
|
|
(344 |
) |
|
|
(397 |
) |
|
Other (expense) income, net |
|
|
(35 |
) |
|
|
111 |
|
|
|
(13 |
) |
|
|
238 |
|
|
Net loss and comprehensive loss |
|
$ |
(1,294 |
) |
|
$ |
(3,670 |
) |
|
$ |
(3,026 |
) |
|
$ |
(7,926 |
) |
|
Net loss per common share, basic and diluted |
|
$ |
(0.07 |
) |
|
$ |
(0.21 |
) |
|
$ |
(0.16 |
) |
|
$ |
(0.46 |
) |
|
Weighted-average shares used to compute net loss per common share, basic and diluted |
|
|
18,747,124 |
|
|
|
17,137,338 |
|
|
|
18,585,339 |
|
|
|
17,117,777 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
1Operating expenses include stock-based compensation as follows: |
|
||||||||||||||||
Research and development |
|
$ |
194 |
|
|
$ |
161 |
|
|
$ |
356 |
|
|
$ |
308 |
|
|
General and administrative |
|
|
646 |
|
|
|
556 |
|
|
|
1,231 |
|
|
|
1,065 |
|
|
Sales and marketing |
|
|
78 |
|
|
|
81 |
|
|
|
136 |
|
|
|
129 |
|
|
Total stock-based compensation |
|
$ |
918 |
|
|
$ |
798 |
|
|
$ |
1,723 |
|
|
$ |
1,502 |
|
|
Reconciliation of GAAP and Non-GAAP Financial Information (In thousands, except share and per share amounts) (Unaudited) |
||||||||||||
Three Months Ended |
||||||||||||
|
|
|
||||||||||
Reconciliation of GAAP and non-GAAP operating expenses |
|
|
|
|
|
|
||||||
GAAP operating expenses |
$ |
6,278 |
|
$ |
6,933 |
|
$ |
7,614 |
|
|||
Reconciling item included in research and development |
|
|
|
|
|
|
||||||
Stock-based compensation |
|
160 |
|
|
137 |
|
|
133 |
|
|||
Reconciling item included in selling, general and administrative |
|
|
|
|
|
|
||||||
Stock-based compensation |
|
724 |
|
|
643 |
|
|
636 |
|
|||
Total reconciling items included in operating expenses |
|
884 |
|
|
780 |
|
|
769 |
|
|||
Non-GAAP operating expenses |
|
$ |
5,394 |
|
|
$ |
6,153 |
|
|
$ |
6,845 |
|
GAAP NET INCOME (LOSS) |
$ |
(1,294 |
) |
$ |
(1,732 |
) |
$ |
(3,670 |
) |
|||
Reconciling items included in operating expenses |
|
|
884 |
|
|
|
780 |
|
|
|
769 |
|
Non-GAAP net income (loss) |
$ |
(410 |
) |
$ |
(951 |
) |
$ |
(2,901 |
) |
|||
Non-GAAP net income (loss) per share, basic and diluted |
|
$ |
(0.02 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.17 |
) |
Weighted average shares to compute net loss per common share, basic and diluted |
|
18,747 |
|
|
18,056 |
|
|
17,137 |
|
Reconciliation of Adjusted EBITDA (In thousands) (Unaudited) |
||||||||||||
Three Months Ended |
||||||||||||
|
|
|
||||||||||
Adjusted EBITDA reconciliation: |
|
|
|
|
|
|
||||||
Net loss |
$ |
(1,294 |
) |
$ |
(1,732 |
) |
$ |
(3,670 |
) |
|||
Depreciation and amortization |
|
|
404 |
|
|
|
409 |
|
|
|
483 |
|
Stock-based compensation expense |
|
918 |
|
|
805 |
|
|
798 |
|
|||
Interest Expense |
|
|
172 |
|
|
|
172 |
|
|
|
186 |
|
Adjusted EBITDA |
$ |
200 |
|
$ |
(346 |
) |
$ |
(2,203 |
) |
Our management and board of directors use Non-GAAP operating expenses, Non-GAAP net income (loss) and Adjusted EBITDA to understand and evaluate our operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operating and financing plans.
Condensed Statement of Cash Flows (In thousands) (Unaudited) |
|||||||||
|
|||||||||
|
|
Six Months Ended |
|
||||||
|
|
2020 |
|
2019 |
|
||||
Cash flows from operating activities |
|
|
|
|
|
|
|
||
Net loss |
|
$ |
(3,026 |
) |
|
$ |
(7,926 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
813 |
|
|
|
876 |
|
|
Loss on disposal of property and equipment |
|
|
— |
|
|
|
20 |
|
|
Stock-based compensation |
|
|
1,723 |
|
|
|
1,502 |
|
|
Non-cash gain on warrant revaluation |
|
|
7 |
|
|
|
— |
|
|
Non-cash interest expense |
|
|
147 |
|
|
|
153 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
||
Accounts receivable |
|
|
(1,540 |
) |
|
|
1,658 |
|
|
Inventory |
|
|
(505 |
) |
|
|
133 |
|
|
Prepaid expenses and other current assets |
|
|
38 |
|
|
|
200 |
|
|
Accounts payable |
|
|
(776 |
) |
|
|
(456 |
) |
|
Accrued liabilities |
|
|
(1,008 |
) |
|
|
(907 |
) |
|
Lease liabilities |
|
|
(73 |
) |
|
|
(43 |
) |
|
Net cash used in operating activities |
|
|
(4,200 |
) |
|
|
(4,790 |
) |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
||
Purchases of property and equipment |
|
|
(277 |
) |
|
|
(461 |
) |
|
Net cash used in investing activities |
|
|
(277 |
) |
|
|
(461 |
) |
|
Cash flows from financing activities |
|
|
|
|
|
|
|
||
Payments on debt |
|
|
— |
|
|
|
(3,000 |
) |
|
Payments on finance lease obligation |
|
|
(5 |
) |
|
|
(5 |
) |
|
Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan |
|
|
827 |
|
|
|
150 |
|
|
Proceeds from issuance of common stock in at-the-market offering, net of issuance costs |
|
|
2,084 |
|
|
|
— |
|
|
Net cash provided by (used in) financing activities |
|
|
2,906 |
|
|
|
(2,855 |
) |
|
Net decrease in cash and cash equivalents |
|
|
(1,571 |
) |
|
|
(8,106 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
14,487 |
|
|
|
23,379 |
|
|
Cash and cash equivalents at end of period |
|
$ |
12,916 |
|
|
$ |
15,273 |
|
|
Supplementary cash flow information: |
|
|
|
|
|
|
|
||
Interest paid |
|
$ |
197 |
|
|
$ |
257 |
|
|
Operating cash flows paid for operating leases |
|
$ |
862 |
|
|
$ |
837 |
|
|
Financing cash flows paid for finance leases |
|
$ |
5 |
|
|
$ |
5 |
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
||
Right-of-use assets obtained in exchange for new operating leases |
|
$ |
— |
|
|
$ |
23 |
|
|
Increase of right-of-use asset and lease liability due to lease modification |
|
$ |
545 |
|
|
$ |
— |
|
|
Purchase of property and equipment in accounts payable and accrued liabilities |
|
$ |
22 |
|
|
$ |
27 |
|
|
Bonus settled in shares of common stock |
|
$ |
315 |
|
|
$ |
— |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200806006014/en/
Company Contact:
T: 480-347-1099
E: daniel.berenbaum@everspin.com
Investor Relations Contact:
Shelton Group Investor Relations
T: 949-224-3874
E: sheltonir@sheltongroup.com
Source: